Evidence map›Paper›PMID 42317507›Full record

ArticleOpen life sciences2026

Mechanism investigation of

Yilin Wang, Shuang Wang, Zhaoxia Li, Xi Chen, Chengyi Zhang, Xiaoxue Han, Limei Wan, Suiqiang Fan, Yiting Liu, Ziyan Guo and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Open life sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Yilin WangThe First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, 510699, Guangdong, China.
Shuang WangThe Third Affiliated Hospital of Jinzhou Medical University, Jinzhou, 121000, Liaoning, China.
Zhaoxia LiZhuhai Hospital of Integrated Traditional Chinese and Western Medicine, Zhuhai, 519000, Guangdong, China.
Xi ChenCollege of Basic Medicine, Beihua University, Jilin, 132013, China.
Chengyi ZhangCollege of Pharmacy, Beihua University, Jilin, 132013, China.
Xiaoxue HanThe First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, 510699, Guangdong, China.
Limei WanThe First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, 510699, Guangdong, China.
Suiqiang FanThe First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, 510699, Guangdong, China.
Yiting LiuCollege of Basic Medicine, Beihua University, Jilin, 132013, China.
Ziyan GuoCollege of Basic Medicine, Beihua University, Jilin, 132013, China.
Xiaoqiang HuangThe First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, 510699, Guangdong, China.ORCID https://orcid.org/0000-0001-9513-6610
Xiaoze XuThe First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, 510699, Guangdong, China.
Xin ZhouThe First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510699, China.
Bingfeng XingThe First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, 510699, Guangdong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To clarify the therapeutic targets and signaling pathways of

Indexed as

Actinidia arguta total flavonegouthyperuricemianetwork pharmacologyTNF

Identifiers

PMID42317507
PMCPMC13274577

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.